News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Bayer HealthCare Wins European Approval for Xarelto Pill
October 1, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
FRANKFURT, Oct 1 (Reuters) - Bayer's blood thinning pill Xarelto has been approved by the European Commission for the prevention of blood clots after hip or knee replacement surgery, the German drugmaker said on Wednesday.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Europe
MORE ON THIS TOPIC
Rare disease
UniQure Eyes Phase 3 for Huntington’s Gene Therapy Despite Makary’s Apparent Criticism
March 2, 2026
·
3 min read
·
Heather McKenzie
Approvals
Ascendis Enters Achondroplasia Arena as FDA Approves First Weekly Drug
March 2, 2026
·
2 min read
·
Tristan Manalac
Regulatory
FDA Action Alert: BMS, GSK, Aldeyra and More
March 2, 2026
·
4 min read
·
Tristan Manalac
FDA
FDA To Offer Bonus Payments for Speedy Drug Reviewers
February 27, 2026
·
1 min read
·
Annalee Armstrong
